Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Takeda discovers new PARP inhibitors

Aug. 17, 2010

FDA grants orphan drug status to BC-819 in pancreatic cancer

Aug. 16, 2010

EMA validates CTI's expanded pediatric program for pixantrone in NHL

Aug. 16, 2010

Syndax raises funds for ENCORE-301 trial in breast cancer

Aug. 16, 2010

AVEO completes enrollment in phase III tivozanib trial in renal cell carcinoma

Aug. 16, 2010

MK-4827 receives E.U. orphan drug status in ovarian cancer

Aug. 16, 2010

Italian researchers discover new SMO receptor antagonists for cancer

Aug. 16, 2010

European Commission grants orphan status to bosutinib in CML

Aug. 13, 2010

Astex and Multiple Myeloma Research Consortium start phase II AT-7519 trial

Aug. 13, 2010

Phase III panitumumab trial in head and neck cancer does not meet primary endpoint

Aug. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...